Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9670506
Modified immunization vectors
granted -
US 9670251
ANG-(1-7) derivative oligopeptides and methods for using and producing the same
granted -
US 9663585
Anti-DCLK1 monoclonal antibodies and methods of production and use thereof
granted -
US 9662424
Hydrogel membrane for adhesion prevention
granted -
US 9663504
Salts of heterocyclic modulators of HIF activity for treatment of disease
granted -
US 9656001
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 9655909
Personalized medicine for the prediction of therapy targeting the hedgehog pathway
granted -
US 9649373
Neoseptins: small molecule adjuvants
granted -
US 9649344
Methods and compositions for in vivo induction of pancreatic beta cell formation
granted -
US 9650436
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
granted -
US 9642859
Use of capsazepine and analogs thereof to treat cancer
granted -
US 9645139
Neuroprotective chemicals and methods for identifying and using same
granted -
US 9638639
Plasmonic-magnetic bifunctional nanotubes for biological applications
granted -
US 9629877
Human application of engineered chimeric antigen receptor (CAR) T-cells
granted -
US 9629914
Heparosan-based biomaterials and coatings and methods of production and use thereof
granted -
US 9631041
PH-sensitive compositions for delivery of beta lapachone and methods of use
granted -
US 9630990
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
granted -
US 9624283
Peptide compounds and methods of production and use thereof
granted -
US 9624484
Engineered primate L-methioninase for therapeutic purposes
granted -
US 9624255
Carbohydrate-mediated tumor targeting
granted -
US 9622974
Formation of stable submicron peptide or protein particles by thin film freezing
granted -
US 9624211
Anti-cancer compounds
granted -
US 9623103
Arterivirus protein and expression mechanisms
granted -
US 9616048
Anti-depression compounds
granted